Medical Oncology
肿瘤内科 · The First Affiliated Hospital of Guangxi Medical University, Nanning
This department is designated as a key clinical specialty for tumor diagnosis and treatment by the Ministry of Health. It integrates medical care, health maintenance, teaching, and research. The unit leads several regional professional organizations, including the Guangxi Tumor Chemotherapy Quality Control Center. It operates three wards and a dedicated clinical laboratory with over 180 beds. The medical team includes more than 20 physicians, all holding senior titles or master’s degrees, alongside over 40 nurses. Treatment approaches focus on standardized comprehensive care, utilizing chemotherapy, targeted therapy, immunotherapy, endocrine therapy, interventional therapy, and hyperthermia to serve patients with various tumors.
Conditions and treatments
- Chemotherapy
- Targeted therapy
- Immunotherapy
- Endocrine therapy
- Interventional therapy
- Hyperthermia
Key facts
- Designated as a key clinical specialty for tumor diagnosis and treatment by the Ministry of Health
- Operates over 180 beds across three wards and one clinical laboratory
- Staff includes more than 20 physicians and over 40 nurses
Rewritten in English from the department's own description on a public doctor-listing platform. Claims such as "leading" are the hospital's own.
| Specialty | Medical Oncology |
|---|---|
| Doctors listed | 37 |
| Chief physicians | 1 |
Senior doctors
Chief and associate chief physicians listed for this department on public doctor-listing platforms (2025–2026).
Chief physicians
- Xiaohua Hu胡晓桦 · Professor
Associate chief physicians
- Na Bu卜娜
- Qing Bu卜庆
- Zhiming Zeng曾智明
- Yang Li李扬
- Dong Lan蓝东
- Haiping Zheng郑海平
We are an independent coordination service, not part of this hospital. Names and titles change; the hospital's website is the final word. How we build this directory.
Need a specialist's opinion?
Send your records and question. We find a specialist in the right field who reviews your case and tells you what they recommend.
Contact us